The first studies of bexarotene in animal models of breast cancer were in the NMU rat model of mammary carcinogenesis, wherein the carcinogen N-nitro-N-methylurea (NMU) initiates the formation of estrogen receptor positive (ER +) mammary tumors12. Here, ESR1 is linked to breast carcinoma.